Ben-Ami et al. previously demonstrated RUNX1 enhances the viability of preleukemic AML1-ETO-expressing cells [21], therefore it may be that RUNX1B activity specifically enhances a preleukemic phenotype in emerging CBF AML leukemia propagating cells. This evidence concerns the gene RUNX1T1 and acute myeloid leukemia.